首页TWST • NASDAQ
add
Twist Bioscience Corp
昨日收盘价
$43.28
当日价格范围
$43.57 - $45.31
年度波幅
$23.30 - $57.88
市值
27.17亿 USD
平均交易量
139.01万
市盈率
-
股息率
-
主要交易所
NASDAQ
相关资讯
财务信息
损益表
收入
净收入
| (USD) | 2025年12月info | 年同比变化 |
|---|---|---|
收入 | 1.04亿 | 16.89% |
经营支出 | 8687.20万 | 12.12% |
净收入 | -3050.70万 | 3.44% |
净利润率 | -29.42 | 17.38% |
每股收益 | -0.50 | 5.66% |
息税折旧摊销前利润 | -2700.60万 | 5.45% |
有效税率 | -0.84% | — |
资产负债表
总资产
负债总额
| (USD) | 2025年12月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 1.98亿 | -26.91% |
总资产 | 6.38亿 | 4.85% |
负债总额 | 1.82亿 | 19.23% |
权益总额 | 4.56亿 | — |
发行在外的股份 | 6131.17万 | — |
市净率 | 5.82 | — |
资产回报率 | -12.85% | — |
资本回报率 | -14.52% | — |
现金流
现金净变动
| (USD) | 2025年12月info | 年同比变化 |
|---|---|---|
净收入 | -3050.70万 | 3.44% |
来自运营的现金 | -2481.40万 | -15.80% |
投资现金 | -993.30万 | -546.68% |
融资现金 | 29.80万 | -98.34% |
现金净变动 | -3444.00万 | -578.89% |
自由现金流 | -2585.55万 | -130.04% |
简介
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
CEO
成立时间
2013
员工数量
979
